English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

This study evaluated the safety of sub-acute administration of Terminalia catappa L. aqueous leaf extract (TCA) on cardiac biochemical parameters. Graded concentrations (200, 400 and 800 mg/kg) of TCA wereorally administered daily for 28 days. Cardiac biochemical parameters of toxicity were thereafter accessedusing standard methods forsuperoxide dismutase, peroxidase, glutathione-S-transferase, reduced glutathione, lipid peroxidation, protein levels, cholesterol, triglyceride, lactate dehydrogenase and creatinine kinase. TCA treatment did not alter the heart weight and cardiac biochemical parameters. Nonetheless, at 800 mg/kg, the antioxidant profile was significantly improved after TCA treatment. There was no mediated sign of treatment toxicityas well asa change in cardiac histological architecture. T. catappaaqueous leaf extract is relatively non-toxic to the heart at the experimental doses and also within the test period.

Safety evaluation of Terminalia catappaLinn (Combretaceae) aqueous leaf extract: Sub-acute cardio-toxicopathological studies in albino Wistar rats